Overview of Dr. Brooks
Dr. Joel Brooks is an allergist/immunologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, and Children's National Hospital. He received his medical degree from Chicago College of Osteopathic Medicine at Midwestern University and has been in practice 4 years. He is one of 27 doctors at Children's National Hospital and one of 24 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Allergy & Immunology. He has more than 10 publications and over 150 citings.
Office
3959 Broadway
New York, NY 10032Fax+1 212-305-4538
Education & Training
Yale-New Haven Medical CenterFellowship, Allergy and Immunology, 2017 - 2019
UPMC Medical Education/LititzResidency, Internal Medicine, 2013 - 2016
Chicago College of Osteopathic Medicine at Midwestern UniversityClass of 2013
Certifications & Licensure
NY State License 2022 - 2025
DC State License 2019 - 2022
MD State License 2019 - 2022
CT State License 2016 - 2021
PA State License 2013 - 2016- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Internal Medicine Internal Medicine
- AOA Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 2 citationsPearls and pitfalls in food protein-induced enterocolitis syndrome (FPIES).Stella Hartono, Elena Zidan, Prasiksha Sitaula, Joel P Brooks
Allergy and Asthma Proceedings. 2023-09-01 - 1 citationsCase Report: Insulin hypersensitivity in youth with type 1 diabetes.Einas H Alkhatib, Jody B Grundman, Anna M Adamusiak, Melena D Bellin, Joel P Brooks
Frontiers in Endocrinology. 2023-01-01 - Correction to: Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients.Hasan Hashem, Giorgia Bucciol, Seza Ozen, Sule Unal, Ikbal Ok Bozkaya
Journal of Clinical Immunology. 2022-10-01
Press Mentions
Where Does Nasal Spray Epinephrine Fit in Allergy Treatment?August 20th, 2024- Children with a History of Allergic Reactions to First Dose of Pfizer COVID-19 Vaccine Can Safely Receive Second DoseJuly 13th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
